Tuoxin Pharmaceutical Group Co.,Ltd.

Tuoxin Pharmaceutical provides the research and development, production and sales of nucleoside (acid) APIs and pharmaceutical intermediates in China. It offers nucleoside (acid) products, such as pyrimidine series, purine series, and nucleotide series.

Its portfolio also includes nucleoside series, including citicoline sodium, ribavirin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, uridine, and APIs and pharmaceutical intermediates covering antiviral, anti-tumor, and nervous system. Founded in 2001, the company is based in Xinxiang, China.